2016 Cancer Annual Report | Page 4

MESSAGE from Renown Institute for Cancer Leadership

A YEAR OF ACTIVE CHANGE
This year , 2016 , has been a year of implementation . The new leadership structure that came in 2015 led to many new programs in 2016 , including :
• $ 8.5M expansion of the Radiation Treatment center , including an improved patient-friendly environment and two new state-of-the-art linear accelerators to provide the most advanced radiation therapy in the region
• Collaborative agreement with community medical oncologists to increase clinical integration and patient coordination .
• Expansion of medical oncology , in preparation for future multidisciplinary centers .
• Expansion of nurse navigation and supportive care programs to enhance the coordination of care .
• Implementation of the first in the region Centers for Medicare & Medicaid Services ( CMS ) approved Lung Cancer Screening Program , assuring access to high risk patients including an on-site shared decision making clinic .
• Enhancement of the Lung Nodule Clinic with Medical Director , Christina Szot , MD .
• New lung diagnostics , including SuperD , advanced technology that allows the physician to reach distant sites in the lung for biopsies .
• Host for northern Nevada ’ s participation in Vice President Joseph Biden ’ s Cancer Moonshot project .
• Expansion of medical oncology outreach , including additional telemedicine sites and outreach clinics .
• Opening of the Cardio-Oncology Program with Christopher Wilson , MD , cardiologist .
This Annual Report provides details of some of these enhancements to our program , and more . The Cancer Registry data also provides information about the cancers we diagnose and treat , along with our Quality Report to include a detailed summary of lung cancer at Renown Institute for Cancer .
Respectfully ,
Christos Galanopoulos , MD , MBA , MS , FACS Renown Health VP and Chief Clinical Officer , Renown Institute for Cancer
Jo Duszkiewicz , MSA Renown Health VP and Administrator , Renown Institute for Cancer
3